KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShort-Term Debt issuancesShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Opko Health (OPK) Free Cash Flow (2016 - 2025)

Opko Health's Free Cash Flow history spans 16 years, with the latest figure at -$28.6 million for Q4 2025.

  • For Q4 2025, Free Cash Flow changed N/A year-over-year to -$28.6 million; the TTM value through Dec 2025 reached -$190.8 million, up 29.93%, while the annual FY2025 figure was -$190.8 million, 8.48% up from the prior year.
  • Free Cash Flow reached -$28.6 million in Q4 2025 per OPK's latest filing, up from -$37.8 million in the prior quarter.
  • In the past five years, Free Cash Flow ranged from a high of $28.9 million in Q3 2023 to a low of -$158.7 million in Q3 2024.
  • Average Free Cash Flow over 5 years is -$32.7 million, with a median of -$28.6 million recorded in 2025.
  • Peak YoY movement for Free Cash Flow: soared 172.54% in 2023, then plummeted 1054.92% in 2024.
  • A 5-year view of Free Cash Flow shows it stood at -$12.4 million in 2021, then tumbled by 206.76% to -$38.0 million in 2022, then dropped by 8.85% to -$41.3 million in 2023, then tumbled by 284.06% to -$158.7 million in 2024, then skyrocketed by 81.98% to -$28.6 million in 2025.
  • Per Business Quant, the three most recent readings for OPK's Free Cash Flow are -$28.6 million (Q4 2025), -$37.8 million (Q3 2025), and -$86.7 million (Q2 2025).